Abstract: Serial blood sampling was conducted to evaluate hormone profiles in entire and surgically castrated male pigs and entire males immunized with gonadotropin-releasing hormone (GnRH) analogue. Immunization reduced plasma concentrations of estrone sulphate and insulin-like growth factor 1 (IGF-1) from entire male concentrations to those observed for surgically castrated males, which likely modulate growth and body composition.
Immunization of entire male pigs against gonadotropin-releasing hormone (GnRH) is effective at reducing the occurrence of boar taint (Dunshea et al. 2001) and influences the dynamics of whole-body protein deposition (PD; Huber et al. 2013) . The endocrine control of these physiological changes, however, remains to be explored in detail. Androgens and estrogens synthesized in the testes stimulate PD, reduce protein degradation, and decrease feed intake in entire male pigs (EM; Asarian and Geary 2002) . Estrogens also stimulate the release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) (Claus and Weiler 1994) . After the second (booster) dose of GnRH analogue, testicular growth is arrested (Dunshea et al. 2001) , and by day 7 after the booster dose, immunized male pigs appear metabolically adapted to the absence of gonadal steroid hormones (Bauer et al. 2009 ). Therefore, there may be relatively rapid changes in circulating concentrations of hormones, including estrogens, IGF-1, and leptin that influence metabolism and energy partitioning after immunization against GnRH. The purpose of this study was to quantify changes in plasma hormones and growth factors after administering the booster dose of GnRH analogue to identify when immunized males deviate from the hormone profiles of EM and become similar to surgical castrates.
The experimental protocol was approved by the University of Guelph Animal Care Committee and followed Canadian Council on Animal Care guidelines (CCAC 2009). Thirty-six male PIC pigs (Floradale Farms, Floradale, ON, Canada) were used for serial blood plasma sampling in three equal blocks of 12 pigs with three pigs per treatment balanced across litters within each block. Four treatments were established: (1) conventional, early castrates (EC), (2) EM, (3) entire male pigs immunized with GnRH analogue (IM), and (4) entire male pigs surgically castrated between 25 and 40 kg body weight (BW) [late castrates (LC)]. The EC and LC were included as controls to determine whether the transient rise in testicular hormones that occurs around 6 wk of age (Booth 1975; Schwarzenberger et al. 1993 ) had lasting effects on circulating hormones and growth factors later in life.
Late castration was conducted by a veterinarian, and the IM were injected subcutaneously behind the ear at approximately 30 kg (primary dose) and 70 kg (booster dose) BW with GnRH analogue [IMPROVEST; Zoetis (formerly Pfizer Animal Health), New York City, NY, USA], as described previously (Huber et al. 2013) . Pigs were fed corn and soybean meal-based diets not limiting in essential nutrients (Huber et al. 2013 ).
Blood was collected approximately 4 h after the morning meal on days −4, −1, 2, 5, 8, 11, 14, 19, 28 , and 37 relative to administration of the booster dose to IM to monitor plasma concentrations of estrone sulphate (E1S), IGF-1, and leptin. Three 5 mL blood samples were collected from the orbital sinus in heparinized vials and centrifuged for 20 min at 1500g and 4°C; plasma was aspirated, placed in microcentrifuge tubes, and frozen at −20°C until further analysis.
Plasma E1S was measured in duplicate using a RIA according to Schwarzenberger et al. (1993) and counted with a liquid scintillation counter (Beckman LS 6000 SC, Ramsey, MN, USA). Assay sensitivity was 0.01 ng mL −1 , and intra-and inter-assay variations were 3.2% and 1.8%, respectively. Plasma IGF-1 was measured in duplicate using a RIA kit (IGF-1 RIA, ALPCO Immunoassays, Salem, NH, USA) and I 125 labelled IGF-1 according to kit instructions, and tubes were counted with an automatic gamma counter (LKB Wallace 1274, Boston, MA, USA). Assay sensitivity was 0.02 ng mL −1 , and intra-and inter-assay variations were 2.6% and 3.4%, respectively. Plasma leptin was measured in duplicate using a multispecies RIA kit (Leptin RIA, Millipore, St. Charles, MO, USA) and I 125 labelled leptin according to kit instructions, and tubes were counted with an automatic gamma counter (LKB Wallace 1274, Boston, MA, USA). The sensitivity was 1 ng mL −1 and intra-and interassay variations were 3.4% and 8.7%, respectively. Statistical analysis for plasma hormone concentrations was conducted using the mixed procedure of SAS with repeated measures (SAS Institute Inc., Cary, NC, USA). The model included the fixed effects of treatment, time (i.e., sampling day), and the interaction between treatment and time, and the random effects of block and litter within block. Preplanned contrasts were constructed to compare treatments within each sampling day: EC vs. LC; EM vs. EC and LC; EM vs. IM; and IM vs. EC and LC. Plasma IGF-1 and leptin values were log transformed, and E1S was double log transformed to normalize the distributions. Probability levels less than 0.05 were considered significant, whereas 0.05 < P < 0.10 was considered a trend and P > 0.10 was considered not significant.
All pigs were healthy except 1 IM and 1 EM, which were excluded due to illness and lameness, respectively. All data from these two pigs were omitted prior to analysis. No behaviour abnormalities were observed, and pigs readily consumed their feed.
There was an interactive effect of treatment and time on plasma E1S concentrations (P < 0.01; Fig. 1A ). Both treatment and time influenced plasma IGF-1 concentrations (P < 0.05; Fig. 1B) , whereas the interactive effect of treatment and time was not significant (P = 0.11). Plasma IGF-1 concentrations were similar between EC and LC throughout the study (overall actual mean values: 220 vs. 226 ng mL ) and lower than those in EM (335 ng mL −1 , P < 0.05). Plasma IGF-1 concentrations were similar in EM and IM up to day 8 (327 vs. 292 ng mL −1 ) and were higher in EM than IM after day 11 (342 vs. 239 ng mL −1 , P < 0. 05). After day 11, plasma IGF-1 concentrations did not differ between IM and EC and LC (222 vs. 225 ng mL
−1
). Treatment and time both influenced plasma leptin concentrations (P < 0.05; Fig. 1C) , whereas the interactive effect of treatment and time tended to be significant (P = 0.06). The EM, EC, and LC generally had similar plasma leptin concentrations throughout the study (overall actual mean values: 2.5 vs. 2.8 vs. 3.0 ng mL −1 , respectively). Plasma leptin concentrations were lower in IM on day −4 and day 2 than those in EM and EC and LC (P < 0.05), but after day 5, there were no differences in plasma leptin concentrations between any treatment groups. Immunization against GnRH influences the rate and composition of BW gain and feed intake (Dunshea et al. 2001; Huber et al. 2013 ). Based on this study, the changes in circulating hormones and growth factors align well with the increased feed intake and reduced PD in entire male pigs immunized with a GnRH analogue. The initial dose of GnRH analogue at approximately 30 kg BW did not influence circulating concentrations of either E1S or IGF-1 when compared with EM, indicating that physiological changes do not occur until the booster dose of GnRH analogue is administered, as previously suggested (Dunshea et al. 2001) . After administering the booster dose, plasma E1S concentrations decreased to those measured in surgical castrates within 8 d and remained low for at least 29 d thereafter. The reduction in E1S concentrations corroborate previous measurements of circulating testicular hormones after administering the booster dose of GnRH analogue (Claus et al. 2007; Bauer et al. 2009 ). Plasma IGF-1 concentrations were reduced from EM to surgical castrate concentrations within 11 d after administering the booster dose of GnRH analogue. The slight delay between reducing E1S and IGF-1 concentrations is likely due to the downstream effects of E1S on IGF-1 production, as well as binding proteins that prolong the half-life of IGF-1 in plasma (Zhou et al. 2003) . In addition, the increase in feed intake that occurs beginning around 7 d after administering the booster dose of GnRH analogue may maintain plasma IGF-1 concentrations for up to 3 d, even though E1S is reduced. With excess energy intake, above that required for maximum PD, IM deposit increased amounts of body lipid (Boler et al. 2011) . Plasma leptin concentrations directly correlate to body fat content, and elevated concentrations result in reduced feed intake and reduced rates of lipid deposition (Campfield et al. 1995) ; however, in this study, plasma concentrations of leptin were rather variable and did not correspond to differences in predicted body composition between the genders (NRC 2012). The initial dose of GnRH analogue may influence plasma leptin concentrations at approximately 70 kg BW (i.e., on day −4 and day 2 relative to administering the booster dose), but this requires further study.
After administering the booster dose of GnRH analogue, plasma concentrations of E1S and IGF-1 were reduced from entire male concentrations to those observed for surgically castrated males within 8 and 11 d, respectively. Such alterations in plasma hormones and growth factors likely modulate changes in the rate and composition of BW gain. Fig. 1 . Plasma estrone sulphate (E1S, log-log ng mL −1 ) (A), IGF-1 (log ng mL −1 ) (B), and leptin (log ng mL −1 ) (C) concentrations in early castrates (EC), entire male pigs (EM), immunized male pigs (IM), and late castrates (LC) across days relative to administer the booster dose of gonadotropin-releasing hormone (GnRH) analogue (day 0) to IM. EC: male pigs surgically castrated within 4 d after birth; EM: entire male pigs; IM: entire male pigs immunized against GnRH at 30 and 70 kg (booster dose) BW; LC: male pigs surgically castrated between 25 and 40 kg BW. 
